These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17060662)

  • 1. Granulocyte colony-stimulating factor.
    Kaptan K; Beyan C; Ifran A
    CMAJ; 2006 Oct; 175(9):1095; author reply 1095-6. PubMed ID: 17060662
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor and hypercoagulability.
    Kaptan K; Beyan C; Ifran A
    Int J Cardiol; 2008 Dec; 131(1):129; author reply 130-1. PubMed ID: 17643524
    [No Abstract]   [Full Text] [Related]  

  • 3. May granulocyte colony-stimulating factor induce hypercoagulable state?
    Kaptan K; Ifran A; Beyan C
    Am Heart J; 2007 Jun; 153(6):e41. PubMed ID: 17540184
    [No Abstract]   [Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
    Wilson RF; Henry TD
    J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor.
    Harriss JP
    CMAJ; 2006 Oct; 175(9):1095; author reply 1095-6. PubMed ID: 17060661
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials.
    Schäbitz WR; Schneider A
    Stroke; 2006 Jul; 37(7):1654; author reply 1655. PubMed ID: 16728676
    [No Abstract]   [Full Text] [Related]  

  • 7. Is short-term effect of granulocyte colony-stimulating factor clearly known?
    Kaptan K; Beyan C; Ifran A
    Am Heart J; 2007 Aug; 154(2):e17; author reply e19. PubMed ID: 17643562
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
    Rosenbaum C; Peace D; Rich E; Van Besien K
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet syndrome associated with granulocyte colony-stimulating factor.
    Bidyasar S; Montoya M; Suleman K; Markowitz AB
    J Clin Oncol; 2008 Sep; 26(26):4355-6. PubMed ID: 18779624
    [No Abstract]   [Full Text] [Related]  

  • 11. Stroke, amyotrophic lateral sclerosis and epilepsy.
    Tear S; Shah S
    IDrugs; 2005 Dec; 8(12):966-7. PubMed ID: 16320123
    [No Abstract]   [Full Text] [Related]  

  • 12. New targets for established proteins: exploring G-CSF for the treatment of stroke.
    Schäbitz WR; Schneider A
    Trends Pharmacol Sci; 2007 Apr; 28(4):157-61. PubMed ID: 17350693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tale of two growth factors.
    Fruehauf JP; Kong KM; Wong SF; Chan HO
    Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.
    Di Campli C; Zocco MA; Saulnier N; Grieco A; Rapaccini G; Addolorato G; Rumi C; Santoliquido A; Leone G; Gasbarrini G; Gasbarrini A
    Dig Liver Dis; 2007 Dec; 39(12):1071-6. PubMed ID: 17964871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor administration: adverse events.
    D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
    Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke.
    Hermann DM; Kilic E
    Stroke; 2008 Nov; 39(11):e182; author reply e183. PubMed ID: 18802202
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

  • 18. Localized cutaneous reactions to granulocyte colony-stimulating factor.
    Samlaska CP; Noyes DK
    Arch Dermatol; 1993 May; 129(5):645-6. PubMed ID: 7683188
    [No Abstract]   [Full Text] [Related]  

  • 19. Re-evaluating the use of growth factors as adjuvant treatment of chronic hepatitis C.
    Worman HJ
    Hepatology; 2007 Oct; 46(4):1307-8; author reply 1307-8. PubMed ID: 17894319
    [No Abstract]   [Full Text] [Related]  

  • 20. Lineage-specific hematopoietic growth factors.
    Dale DC; Rosenberg PS; Alter BP
    N Engl J Med; 2006 Aug; 355(5):526-7; author reply 527. PubMed ID: 16888846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.